The 2018 Workers’ Compensation Drug Trend Report, released by myMatrixx earlier this year, was heavily referenced in a recent article for the Amaxx Work Comp Resource Center. The piece, which discusses the growing concern over rising costs for specialty and name-brand drugs, offers insight for stakeholders trying to keep drug costs down. In particular, the advice was to use lower-cost generic drugs whenever possible and utilize clear communication and controls to avoid unnecessary prescriptions and misuse.
The article quotes the myMatrixx report in several instances, including a demonstration of the price disparity between name-brands and generics, as well as figures showing the high costs of certain specialty drugs. The conclusion of the piece mirrored the same overall goals of the Drug Trend Report — namely, to ensure injured workers get the medication they need while avoiding exorbitant expenditure on the part of stakeholders.